Study Group: Psychiatrists (EU)(?)

This brief news is warning againts any procedural delay to market prices of generic versions of brand-name drugs. The eventual outcome is unexpected overpayment for generic brand. Is this a problem arising from computer pricing or a stratetgic decision making issue on how to label generic drugs...

The article is indicating ethical measures from the FDA relating to the risk of developing cardiovascular disease from using type 2 diabetes drug. An interesting idea for medical intervention in which decision making is underway to assess the efficacy of clinical trials...

This news has limited implications for drug development due to the mystery surrounding the causes of Alzheimer's disease. The research reported in this news article is mainly examining the potential primary role of beta-amyloid plaque to cause the onset of Alzheimer's disease. The research is useful...

The news reported in this article is no doubt showing an excellent progress made in diagnostic technique for various major illnesses, for which brain scanner is used. PET has been used to detect neurological disorder for a long time, and an additional development can ensure the successful application...

A valuable piece of information indicating an achievement to regulate and control severity of type 2 Diabetes. The article reports the findings of a clinical trial in details, the interesting outcome of weight loss in addition to blood sugar reduction may serve as indicators of possible success for...